Chronic pain after herniorraphy pregabalin versus placebo.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 18 Aug 2011
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 02 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by NTr record.
- 23 Sep 2009 Lead trial centre and sponsor (Pfizer) added as reported by Netherlands Trial Register.
- 23 Sep 2009 New source identified and integrated Netherlands Trial Register record).